ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 396 filers reported holding ENCOMPASS HEALTH CORP in Q2 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $711,297,000 | -38.3% | 12,693 | -21.7% | 0.41% | +25.8% |
| Q1 2022 | $1,152,835,000 | +8.2% | 16,213 | -0.7% | 0.32% | +26.0% |
| Q4 2021 | $1,065,527,000 | +430.8% | 16,328 | +510.4% | 0.26% | +437.5% |
| Q3 2021 | $200,725,000 | -12.5% | 2,675 | -6.5% | 0.05% | -7.7% |
| Q2 2021 | $229,527,000 | +163.7% | 2,862 | +169.2% | 0.05% | +108.0% |
| Q1 2021 | $87,056,000 | -57.9% | 1,063 | -57.5% | 0.02% | -59.0% |
| Q4 2020 | $206,963,000 | +186.2% | 2,503 | +124.9% | 0.06% | +190.5% |
| Q3 2020 | $72,319,000 | +4.9% | 1,113 | 0.0% | 0.02% | +16.7% |
| Q2 2020 | $68,923,000 | -3.3% | 1,113 | 0.0% | 0.02% | -10.0% |
| Q1 2020 | $71,262,000 | -27.8% | 1,113 | -12.6% | 0.02% | +11.1% |
| Q4 2019 | $98,703,000 | +22.5% | 1,274 | 0.0% | 0.02% | +28.6% |
| Q3 2019 | $80,603,000 | -0.1% | 1,274 | 0.0% | 0.01% | 0.0% |
| Q2 2019 | $80,690,000 | +8.5% | 1,274 | 0.0% | 0.01% | -6.7% |
| Q1 2019 | $74,373,000 | +109.0% | 1,274 | +120.8% | 0.02% | +150.0% |
| Q4 2018 | $35,590,000 | – | 577 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JANA PARTNERS LLC | 2,001,897 | $150,222,000 | 11.74% |
| JET CAPITAL INVESTORS L P | 855,100 | $64,167,000 | 10.95% |
| Davide Leone & Partners Investment Co Ltd. | 735,308 | $55,178,000 | 4.23% |
| Kent Lake Capital LLC | 110,000 | $8,254,000 | 3.55% |
| REINHART PARTNERS, LLC. | 604,274 | $53,309,000 | 2.71% |
| AREX Capital Management, LP | 74,000 | $5,553,000 | 2.59% |
| RK Capital | 179,800 | $13,492,000 | 2.55% |
| Orchard Capital Management, LLC | 108,266 | $8,124,000 | 2.44% |
| BARINGTON CAPITAL GROUP, L.P. | 24,200 | $1,816,000 | 1.88% |
| Sivik Global Healthcare LLC | 100,000 | $7,504,000 | 1.79% |